Market Place
Sourcing Support
Pliant’s Bexotegrast Data Highlighted At The Liver Meeting® 2024
17 Oct 2024 //
GLOBENEWSWIRE
Pliant Presents Bexotegrast Data At Respiratory Congress
10 Sep 2024 //
GLOBENEWSWIRE
Pliant Reports Positive Long-Term Data From INTEGRIS-PSC Phase 2a Trial
15 Jul 2024 //
GLOBENEWSWIRE
Pliant Presents Data From Bexotegrast Program At EASL International Congress
06 Jun 2024 //
GLOBENEWSWIRE
Pliant Presents Bexotegrast Data At American Thoracic Society Conference
21 May 2024 //
GLOBENEWSWIRE
Pliant Announces Positive Phase 2a Bexotegrast IPF Imaging Data
14 May 2024 //
GLOBENEWSWIRE
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan
12 Mar 2024 //
GLOBENEWSWIRE
Pliant Therapeutics Presentations at Liver Meeting 2023 Highlight Bexotegrast
13 Nov 2023 //
GLOBENEWSWIRE
Pliant Therapeutics Phase 2a Data Evaluating Bexotegrast to be Highlighted
19 Oct 2023 //
GLOBENEWSWIRE
Pliant Announces Safety Data from Phase 2a Trial of Bexotegrast
26 Sep 2023 //
GLOBENEWSWIRE
Pliant Announces Initiation of BEACON-IPF, a Phase 2b Trial of Bexotegrast
09 Aug 2023 //
GLOBENEWSWIRE
Pliant Therapeutics Presents Data from its Bexotegrast Program at EASL
24 Jun 2023 //
PRESS RELEASE
Pliant Therapeutics Presents Data from its Bexotegrast Program at (EASL)
23 Jun 2023 //
GLOBENEWSWIRE
Pliant Announces +ve Long-Term Data fromthe INTEGRIS-IPF Ph2a Trial Bexotegrast
30 Apr 2023 //
GLOBENEWSWIRE
Pliant Therapeutics begins subject enrolment in bexotegrast trial
14 Mar 2023 //
CLINICAL TRIALS ARENA
Pliant Announces Initiation of Enrollment of Phase 2a Trial of Bexotegrast
13 Mar 2023 //
GLOBENEWSWIRE
Pliant surges on positive data for lung fibrosis drug bexotegrast
24 Jan 2023 //
GLOBENEWSWIRE
Pliant Therapeutics Receives Orphan Designation from the EMA for Bexotegrast
15 Dec 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.